First Long Island Investors, LLC Abbott Laboratories Transaction History

First Long Island Investors, LLC

$1.18 Billion
Q1 2024

A detailed history of First Long Island Investors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, First Long Island Investors, LLC holds 341,791 shares of ABT stock, worth $35 Million. This represents 3.28% of its overall portfolio holdings.

Number of Shares

341,791

Previous 344,843 0.89%

Holding current value

$35 Million

Previous $38 Million 2.35%

% of portfolio

3.28%

Previous 3.41%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $334,255 - $369,169	-3,052 Reduced 0.89%	341,791 $38.8 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $2.45 Million - $3 Million	27,150 Added 8.55%	344,843 $38 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $116,068 - $139,263	-1,215 Reduced 0.38%	317,693 $30.8 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $993,086 - $1.11 Million	-9,854 Reduced 3.0%	318,908 $34.8 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $1.18 Million - $1.39 Million	-12,164 Reduced 3.57%	328,762 $33.3 Million

Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $39,830 - $46,726	419 Added 0.12%	340,926 $37.4 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $96,082 - $111,245	-993 Reduced 0.29%	340,507 $32.9 Million
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $888,825 - $1.07 Million	-8,708 Reduced 2.49%	341,500 $37.1 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $3.54 Million - $4.32 Million	-31,041 Reduced 8.14%	350,208 $41.5 Million
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $314,241 - $384,771	2,720 Added 0.72%	381,249 $53.7 Million
Q3 2021 Nov 01, 2021	BUY	$116.66 - $129.06 $1 Million - $1.11 Million	8,601 Added 2.33%	378,529 $44.7 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $849,282 - $999,726	-8,028 Reduced 2.12%	369,928 $42.9 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $308,017 - $362,890	-2,830 Reduced 0.74%	377,956 $45.3 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $539,175 - $587,546	-5,135 Reduced 1.33%	380,786 $41.7 Million
Q3 2020 Nov 17, 2020	SELL	$91.64 - $111.29 $328,895 - $399,419	-3,589 Reduced 0.92%	385,921 $42 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $2.36 Million - $3.02 Million	30,829 Added 8.6%	389,510 $35.6 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $4.09 Million - $5.98 Million	65,133 Added 22.19%	358,681 $28.3 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $334,060 - $371,887	4,255 Added 1.47%	293,548 $25.5 Million
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $1.4 Million - $1.52 Million	-17,099 Reduced 5.58%	289,293 $24.2 Million
Q2 2019 Aug 05, 2019	SELL	$72.88 - $85.0 $1.03 Million - $1.2 Million	-14,109 Reduced 4.4%	306,392 $25.8 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $719,612 - $870,012	10,867 Added 3.51%	320,501 $25.6 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $1.34 Million - $1.52 Million	-20,420 Reduced 6.19%	309,634 $22.4 Million
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $687,457 - $829,334	-11,305 Reduced 3.31%	330,054 $24.2 Million
Q2 2018 Aug 08, 2018	SELL	$57.57 - $63.54 $1.68 Million - $1.85 Million	-29,126 Reduced 7.86%	341,359 $20.8 Million
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $2.87 Million - $3.25 Million	-51,069 Reduced 12.11%	370,485 $22.2 Million
Q4 2017 Feb 07, 2018	BUY	$53.68 - $57.47 $134,629 - $144,134	2,508 Added 0.6%	421,554 $24.1 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $6.55 Million - $7.31 Million	136,242 Added 48.18%	419,046 $22.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	282,804	282,804 $0

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Long Island Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Long Island Investors, LLC with notifications on news.

Account

First Long Island Investors, LLC Abbott Laboratories Transaction History